Barriers to Mohs Micrographic Surgery in Japanese Patients With Basal Cell Carcinoma.

Cutis

Dr. Suzuki is from Takadanobaba Dermatology & Plastic Surgery, Tokyo, Japan. Dr. Kim is from US Naval Hospital Yokosuka, Japan. Dr. Barlow is from Naval Medical Center San Diego, California.

Published: July 2024

Mohs micrographic surgery (MMS) is a well-recognized treatment for nonmelanoma skin cancer worldwide, but Japan has lagged behind many other countries in adopting MMS. We present a series of 5 cases of MMS utilized in Japanese patients. All cases had a favorable outcome, each benefiting from MMS with a smaller final defect or a higher likelihood of cure than standard excision. Slow adaptation of MMS in Japan likely is due to a lack of familiarity with the technique, lack of a training pipeline for physicians, barriers to payment for the procedure, and misconceptions among Japanese physicians. Our case series demonstrates the utility of MMS in treating skin cancer among Japanese patients.

Download full-text PDF

Source
http://dx.doi.org/10.12788/cutis.1057DOI Listing

Publication Analysis

Top Keywords

japanese patients
12
mohs micrographic
8
micrographic surgery
8
skin cancer
8
mms
6
barriers mohs
4
japanese
4
surgery japanese
4
patients basal
4
basal cell
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!